9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d
Re. Questionnaire on Medical Fitness to Drive / Mental disorders
Dear Sir or Madam
On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group
called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to
send you a questionnaire concerning psychiatric illness/mental health.
The CIECA Topical Group ”Setting Standards for the Evaluation of Medical Fitness to Drive”
was created in February 2018. One of its aims is to make comparisons between European
countries with regards to standards and procedures in evaluating Medical Fitness to Drive.
The results of such a comparison will be to find best practices through discussions between
representatives from different European countries. Furthermore, the Topical group also aims
at giving input to the EU Commission on suggestions for changes in the Annex III of the EU
directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU;
2016/116) as they are in need of updating in certain areas. The relevant section of the 2006
Directive relating to psychiatric Illness/mental health is attached at the end of this letter and
before the questionnaire.
Your input to describe the procedures in your country when it comes to psychiatric
illness/mental health is very important and we hope that you, by giving this information, will
assist in the work to get better and updated EU rules within this field. In this aspect it is
especially important that the views of relevant experts (medical doctors, psychologists, etc.)
in your organisation are included. If you are not the best person to answer this
questionnaire, we hope that you will be able to deliver it to the relevant expert.
The information that you provide will be accessed directly only by CIECA employees and
members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical
Group. The data will be coded and uploaded onto a password protected server in CIECA.
Your contact details will be accessible only by CIECA employees in compliance with the terms
of GDPR regulation.
Please note that this questionnaire should be filled in on your computer and returned by e-
mail to
[email protected] at your earliest convenience, ideally before 15 January 2019.
To fill in the questionnaire just click on the grey boxes and start writing. Move to the next
question with the TAB key
1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA
currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic
education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu.
1
9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d
and tick either the Yes or No box ( ) with the space key or with the left mouse button.
We would like to thank you in advance for your kind collaboration!
Kind regards
Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the
CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group
CIECA Secretariat
Avenue de Tervueren 36-38
B-1040 Brussels
T +32 2 732 72 30
www.cieca.eu
[email protected]
The section of the 2006/126/EC Directive relating to psychiatric Illness/mental health:
“MENTAL DISORDERS
Group 1:
13.1. Driving licences shall not be issued to, or renewed for, applicants or drivers who suffer
from:
— severe mental disturbance, whether congenital or due to disease, trauma or neurosurgical
operations,
— severe mental retardation,
— severe behavioural problems due to ageing; or personality defects leading to seriously
impaired judgment, behaviour or adaptability,
unless their application is supported by authorised medical opinion and, if necessary, subject
to regular medical check-ups.
Group 2:
13.2. The competent medical authority shall give due consideration to the additional risks
and dangers involved in the driving of vehicles covered by the definition of this group.”
2
9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d
QUESTIONNAIRE
Please indicate YOUR COUNTRY here:
Q 1: How is psychiatric illness (e.g. schizophrenia spectrum and psychotic disorders, depressive and
anxiety disorders, bipolar disorders, obsessive-compulsive disorders, trauma and stressor-related
disorders, eating disorders, addictive disorders, personality disorder (BUT NOT neurodevelopmental
disorders [autism, ADHD and disruptive behaviour disorders which is covered in a separate
questionnaire])) notified to the Driving Licensing authority in your country?
Give details here:
Q 2: Please describe the process from notifying psychiatric illness (e.g. schizophrenia spectrum and
psychotic disorders, depressive and anxiety disorders, bipolar disorders, obsessive-compulsive
disorders, trauma and stressor-related disorders, eating disorders, addictive disorders, personality
disorder (BUT NOT neurodevelopmental disorders [autism, ADHD and disruptive behaviour disorders
which is covered in a separate questionnaire])) to obtaining or retaining driving license for group 1
and group 2.
Give details here:
Q 3: Are on-road driving assessments used as part of the medical fitness to drive process for drivers
with psychiatric illness (e.g. schizophrenia spectrum and psychotic disorders, depressive and anxiety
disorders, bipolar disorders, obsessive-compulsive disorders, trauma and stressor-related disorders,
eating disorders, addictive disorders, personality disorder(BUT NOT neurodevelopmental disorders
[autism, ADHD and disruptive behaviour disorders which is covered in a separate questionnaire]))?
Yes
No
Remarks:
Q 3a: If so, please describe when on-road driving assessments are used in the medical
fitness to drive process for drivers with psychiatric illness.
Give details here:
Q 3b: If so, please describe which professionals are involved in this.
Give details here:
3
9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d
Q 4: Do you feel advice given in the Annex III for psychiatric illness/mental health is adequate and
appropriate?
Yes
No
Remarks:
Q 5: If your answer is NO then please provide suggestions as to how they should be adapted in
following box.
Details:
Thank you for your cooperation!
4
7299112e-7a0b-40d4-a1e2-ebfcc89d4995
Re. Questionnaire on Medical Fitness to Drive / Neurodevelopmental conditions
Dear Sir or Madam
On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group
called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to
send you a questionnaire concerning neurodevelopmental conditions starting at young age.
The CIECA Topical Group ”Setting Standards for the Evaluation of Medical Fitness to Drive”
was created in February 2018. One of its aims is to make comparisons between European
countries with regards to standards and procedures in evaluating Medical Fitness to Drive.
The results of such a comparison will be to find best practices through discussions between
representatives from different European countries. Furthermore, the Topical group also aims
at giving input to the EU Commission on suggestions for changes in the Annex III of the EU
directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU;
2016/116) as they are in need of updating in certain areas.
Your input to describe the procedures in your country when it comes to safety impairments
due to neurodevelopmental conditions is very important and we hope that you, by giving
this information, will assist in the work to get better and updated EU rules within this field.
In this aspect it is especially important that the views of relevant experts (medical doctors,
psychologists, etc.) in your organisation are included. If you are not the best person to
answer this questionnaire, we hope that you will be able to deliver it to the relevant expert.
The information that you provide will be accessed directly only by CIECA employees and
members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical
Group. The data will be coded and uploaded onto a password protected server in CIECA.
Your contact details will be accessible only by CIECA employees in compliance with the terms
of GDPR regulation.
Please note that this questionnaire should be filled in on your computer and returned by e-
mail to
[email protected] at your earliest convenience, ideally before 15 January 2019.
To fill in the questionnaire just click on the grey boxes and start writing. Move to the next
question with the TAB key
1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA
currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic
education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu.
1
7299112e-7a0b-40d4-a1e2-ebfcc89d4995
and tick either the Yes or No box ( ) with the space key or with the left mouse button.
We would like to thank you in advance for your kind collaboration!
Kind regards
Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the
CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group
CIECA Secretariat
Avenue de Tervueren 36-38
B-1040 Brussels
T +32 2 732 72 30
www.cieca.eu
[email protected]
2
7299112e-7a0b-40d4-a1e2-ebfcc89d4995
QUESTIONNAIRE NEURODEVELOPMENTAL CONDITIONS
Please indicate YOUR COUNTRY here:
Q 1: How are neurodevelopmental conditions starting at young age notified to the traffic authority
in your country?
Give details here:
Q 2: What kind of diseases are under formal regulation within your country under this term?
Attention deficit hyperactivity disorder (ADHD)
Attention deficit disorder (ADD) without hyperactivity
Asperger´s syndrome
Autism
Learning Disability
Others:
Q 3: Under which condition is it allowed to hold a license if a person suffers from severe
impairments due to reduced neurodevelopmental conditions?
Give details here:
3.a: What are clear cut exclusion criteria?
Give details here:
Q 4: Are these diseases checked as a regular procedure if a young person applies for the driver
licence first time?
Yes
No
Remarks:
Q 5: How do you investigate this?
Give details here:
Q 6: Do you have specific regulations for diseases like ADHD, ADD, Asperger’s syndrome, Autism,
Learning Disability?
3
7299112e-7a0b-40d4-a1e2-ebfcc89d4995
Yes
No
Remarks:
If so,
6.a: What are they?
Give details here:
6.a.i: Do they differ for Group I and II?
Yes
No
Remarks:
6.b: Do the regulations specifically require the assessment of medical fitness to include any
subjective or objective parameters or both?
Yes
No
Remarks:
6.b.i: Which ones, subjective (e.g. anamnesis: experience of symptoms, self
reflection, decicion making strategies, triggering factors… or questionnaire or
personality test) and objective parameters (e.g., performance tests)?
Give details here:
6.c: Do the regulations also specify frequency of follow-up inspections and the proof of
continuous medical care?
Yes
No
Remarks:
Q 7: Do you have suggestions for grading stages of the disease and therefore different
requirements due to fitness to drive?
4
7299112e-7a0b-40d4-a1e2-ebfcc89d4995
Yes
No
Remarks:
Q 8: Do you have specialized medical teams within healthcare system that carry out assessment of
medical fitness to drive in cases of deficits in neurodevelopmental conditions?
Yes
No
Remarks:
Q 9: Do you have on-road assessment in assessing fitness to drive for patients due to impaired
neurodevelopmental conditions?
Yes
No
Remarks:
9.a: If so, how is this done?
Give details here:
Q 10: Do you find anything special in the directives 2006/126/EC and 2009/113/EC, annex III on
neurodevelopmental conditions that you would like to see changed?
Yes
No
Remarks:
Thank you for your cooperation!
5
5a4e0dc3-ad38-4f15-ac23-bf591531d711
Re. Questionnaire on Medical Fitness to Drive / Comorbidity
Dear Sir or Madam
On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group
called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to
send you a questionnaire concerning the issue of comorbidity / multi-pathology.
The CIECA Topical Group ”Setting Standards for the Evaluation of Medical Fitness to Drive”
was created in February 2018. One of its aims is to make comparisons between European
countries with regards to standards and procedures in evaluating Medical Fitness to Drive.
The results of such a comparison will be to find best practices through discussions between
representatives from different European countries. Furthermore, the Topical group also aims
at giving input to the EU Commission on suggestions for changes in the Annex III of the EU
directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU;
2016/116) as they are in need of updating in certain areas.
Your input to describe the procedures in your country when it comes to evaluating fitness to
drive taking into account aspects of comorbidity/multi-pathology is very important and we
hope that you, by giving this information, will assist in the work to get better and updated
EU rules within this field. In this aspect it is especially important that the views of relevant
experts (medical doctors, psychologists, etc.) in your organisation are included. If you are not
the best person to answer this questionnaire, we hope that you will be able to deliver it to
the relevant expert.
The information that you provide will be accessed directly only by CIECA employees and
members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical
Group. The data will be coded and uploaded onto a password protected server in CIECA.
Your contact details will be accessible only by CIECA employees in compliance with the terms
of GDPR regulation.
Please note that this questionnaire should be filled in on your computer and returned by e-
mail to
[email protected] at your earliest convenience, ideally before 15 January 2019.
To fill in the questionnaire just click on the grey boxes and start writing. Move to the next
question with the TAB key
1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA
currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic
education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu.
1
5a4e0dc3-ad38-4f15-ac23-bf591531d711
and tick either the Yes or No box ( ) with the space key or with the left mouse button.
We would like to thank you in advance for your kind collaboration!
Kind regards
Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the
CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group
CIECA Secretariat
Avenue de Tervueren 36-38
B-1040 Brussels
T +32 2 732 72 30
www.cieca.eu
[email protected]
2
5a4e0dc3-ad38-4f15-ac23-bf591531d711
QUESTIONNAIRE
Comorbidity:
There is no agreement on the meaning of the term. Related constructs are multimorbidity, morbidity
burden, and patient complexity.
Comorbidity is here defined as the presence of one or more additional mental, neurodevelopmental,
medical, or physical conditions, diseases or disorders co-occurring with (that is, concomitant or
concurrent with) a primary condition, disease or disorder.
It here is interpreted as the notion of burden of illness or disease, defined by the total burden of
dysfunction and is therefore linked to the concept of total impact on patient-reported outcomes,
including functioning. Hence, the comorbidity concept, as referred to here, reflects not only the
multiplicity of conditions, but also the interactions between them, influencing the total burden of
dysfunction. This total burden is influenced not only by health-related characteristics, but also by
socioeconomic, cultural, environmental, and patient behaviour characteristics.
Comorbidity is associated with worse health outcomes, more complex clinical management, and
increased health care costs.
Please indicate YOUR COUNTRY here:
Q 1: Can your country, in its fitness to drive decision process, take into account the issue of
comorbidity (as defined above)? In other words: Is there any way of taking this into account in any
fitness to drive procedure, recommendation or decision?
Yes
No
Give details here:
Q 2: Does your country, in its legally defined fitness to drive requirements/ national guidelines,
take into account the issue of comorbidity (as defined above)?
Yes
No
Give details here:
Q 3: Does your country, in its requirements pertaining to medical assessment, take into account
the issue of comorbidity (as defined above)?
Yes
No
Not applicable
3
5a4e0dc3-ad38-4f15-ac23-bf591531d711
Give details here:
Q 4: Does your country, in its requirements pertaining to psychological assessment, take into
account the issue of comorbidity (as defined above)?
Yes
No
Not applicable
Give details here:
Q 5: Does your country, in its requirements pertaining to practical driving assessment take into
account the issue of comorbidity (as defined above)?
Yes
No
Not applicable
Give details here:
Q 6: Are you aware of any method of quantification of the concept of comorbidity as defined
above?
Yes
No
Give details here:
Q 7: Can any undocumented issue of comorbidity pose a problem related to professional or
medical secrecy? (For example, in case an issue of comorbidity is discovered but this was not the
primary reason for the fitness to drive evaluation.)
Yes
No
Give details here:
Thank you for your cooperation!
4
8019e8d3-7ad9-44fa-b440-e43e6fb49cef
Re. Questionnaire on Medical Fitness to Drive / Sleep apnea
Dear Sir or Madam
On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group
called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to
send you a questionnaire concerning sleep apnea.
The CIECA Topical Group “Setting Standards for the Evaluation of Medical Fitness to Drive”
was created in February 2018. One of its aims is to make comparisons between European
countries with regards to standards and procedures in evaluating Medical Fitness to Drive.
The results of such a comparison will be to find best practices through discussions between
representatives from different European countries. Furthermore, the Topical group also aims
at giving input to the EU Commission on suggestions for changes in the Annex III of the EU
directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU;
2016/116) as they are in need of updating in certain areas.
Your input to describe the procedures in your country when it comes to sleep apnea is very
important and we hope that you, by giving this information, will assist in the work to get
better and updated EU rules within this field. In this aspect it is especially important that the
views of relevant experts (medical doctors, psychologists, etc.) in your organisation are
included. If you are not the best person to answer this questionnaire, we hope that you will
be able to deliver it to the relevant expert.
The information that you provide will be accessed directly only by CIECA employees and
members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical
Group. The data will be coded and uploaded onto a password protected server in CIECA.
Your contact details will be accessible only by CIECA employees in compliance with the terms
of GDPR regulation.
Please note that this questionnaire should be filled in on your computer and returned by e-
mail to
[email protected] at your earliest convenience, ideally before 15 January 2019.
To fill in the questionnaire just click on the grey boxes and start writing. Move to the next
question with the TAB key
1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA
currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic
education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu.
1
8019e8d3-7ad9-44fa-b440-e43e6fb49cef
and tick either the Yes or No box ( ) with the space key or with the left mouse button.
We would like to thank you in advance for your kind collaboration!
Kind regards
Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the
CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group
CIECA Secretariat
Avenue de Tervueren 36-38
B-1040 Brussels
T +32 2 732 72 30
www.cieca.eu
[email protected]
2
8019e8d3-7ad9-44fa-b440-e43e6fb49cef
QUESTIONNAIRE
Please indicate YOUR COUNTRY here:
Q 1: How is sleep apnea notified to the authority in your country?
Give details here:
Q 2: Under which conditions are drivers with sleep apnea allowed to hold a license?
Give details here:
Q 3: How do you investigate this?
Give details here:
Q 4: Do you have specific regulations for narcolepsy or other central disorders of hypersomnolence
(idiopathic hypersomnia, Klein-Levin syndrome)?
Yes
No
Remarks:
If so,
4.a: Which diseases are covered by the specific regulations?
Give details here:
4.a.i: Do the regulations differ for Group I and II?
Yes
No
Remarks:
4.b: Do the regulations require that assessment of medical fitness includes assessment of
subjective or objective parameters or both? If so, which ones?
No requirement in the regulations
Yes, subjective parameters to be assessed
Yes, objective parameters to be assessed
3
8019e8d3-7ad9-44fa-b440-e43e6fb49cef
Yes, both subjective and objective parameters to be assessed
Remarks:
4.c: Do the regulations cover the use of any medication for narcolepsy?
Yes
No
Remarks:
4.d: Do the regulations also specify frequency of follow ups?
Yes
No
Remarks:
Q 5: Do you have any suggestions for what a relevant regulation for narcolepsy and/or other
central disorders of hypersomnolence should include?
If yes, give details here:
Q 6: Do you have specialized medical teams within the healthcare system that carry out
assessment of medical fitness to drive when it comes to sleep apnea or narcolepsy?
Yes
No
Remarks:
Q 7: Do you have on-road assessment when assessing fitness to drive for patients with sleep apnea
or narcolepsy?
Yes
No
Remarks:
7.a: If so, how is on-road assessment done (eg length, content, procedure)?
Give details here:
4
8019e8d3-7ad9-44fa-b440-e43e6fb49cef
Q 8: Is there anything specific in the directives 2006/126/EC and 2009/113/EC, annex III on sleep
apnea and narcolepsy that you would like to see changed?
Yes
No
If yes, give details here:
If no, please explain why:
Thank you for your cooperation!
5
Saatja: Kairi Kimber <
[email protected]>
Saadetud: 18.01.2019 09:42
Adressaat: SM Info <
[email protected]>
Teema: CIECA Questionnaires - Fitness to Drive evaluation procedure (batch 2)
Tähtsus: Kõrgeim
Manused: 2018-08-QUEST_Medical-Fitness-to-Drive_6 SLEEP APNEA final.doc; 2018-08-
QUEST_Medical-Fitness-to-Drive_7 MENTAL DISORDERS final.doc; 2018-08-
QUEST_Medical-Fitness-to-Drive_8 NEURODEVELOPMENTAL final.doc; 2018-08-
QUEST_Medical-Fitness-to-Drive_9 COMORBIDITY final.doc
Tere
CIECA on saatnud maanteeametile neli k�simustikku. Kuna k�simused on
meditsiinivaldkonnast, siis palume teil neile vastata ja meile tagasi saata hiljemalt 18.02.2019.
Kirjas on palutud t�itmiseks kaasata ka arste.
Lugupidamisega
Kairi Kimber
peaspetsialist | eksamiosakond
636 1113 |
[email protected]
Maanteeamet
Teelise 4 | 10916 Tallinn
From: Blanka Wirth <
[email protected]>
Sent: Wednesday, January 16, 2019 11:49 AM
Cc: Augusta Sica <
[email protected]>
Subject: Reminder: CIECA Questionnaires - Fitness to Drive evaluation procedure (batch 2)
Importance: High
Dear CIECA contact person
We would like to kindly remind you of the four questionnaires regarding the Fitness To Drive evaluation
procedure (batch 2, see attached) that were sent on behalf of the CIECA Topical Group� Setting
Standards for the Evaluation of Medical Fitness to Drive�.
The results of the questionnaires are planned to be presented at the next meeting of the group on 11
March 2019.
Please be also reminded that it is especially important to include in this process medical doctors that are
involved in medical driver fitness issues.
Thank you very much in advance for your collaboration!
Kind regards
--------------------------------------
Blanka Wirth
CIECA
T +32 2 732 72 30
www.cieca.eu
[email protected]
Before printing this email, assess if it is really needed